DE:WQ5 Stock Latest News
Company AnnouncementsGenflow strengthens SIRT6 patent in Japan and broadens animal health pipeline3w ago
Company AnnouncementsGenflow’s SIRT6c Gene Therapy Shows Promising Interim Results in Ageing Dog Trial3w ago
Company AnnouncementsGenflow Biosciences boosts capital with warrant exercise and new share issuance1M ago- Company AnnouncementsGenflow Biosciences Hits Canine Longevity Milestone and Expands Human Aging Pipeline1M ago
Company AnnouncementsGenflow hits key ageing marker in dog gene‑therapy trial, eyes animal health deals1M ago
Company AnnouncementsGenflow Biosciences hires ON365 to bolster investor outreach as SIRT6 gene therapy advances1M agoCompany AnnouncementsGenflow Advances SIRT6 Patent Portfolio to Bolster Longevity Gene Therapy Strategy3M ago
Company AnnouncementsGenflow advances SIRT6 longevity platform with positive dog data and new partnerships3M ago
Company AnnouncementsGenflow Wins Strong Shareholder Backing for Governance and New Share Scheme4M ago
Company AnnouncementsGenflow’s Chair to Spotlight Longevity and RNA Therapeutics at BIO 20264M ago
Company AnnouncementsGenflow to Unveil Key Beagle Longevity Trial Data at Animal Summit 20264M ago- Company AnnouncementsGenflow Sets June AGM and Announces Board Change Amid Longevity R&D Push5M ago
Company AnnouncementsGenflow Biosciences expands share capital after warrant exercises5M agoCompany AnnouncementsGenflow Advances SIRT6 Longevity Pipeline as Funding and Canine Trial Progress Bolster Position6M ago
Company AnnouncementsGenflow Secures Fully Funded LNP Collaboration With Acuitas to Advance SIRT6 Gene Therapy6M ago
Company AnnouncementsGenflow widens SIRT6 patent shield with muscular disease program6M ago- Company AnnouncementsGenflow sees sustained safety and efficacy in SIRT6 beagle trial6M ago
- Company AnnouncementsGenflow Biosciences Updates Share Capital and Voting Rights Total7M ago
Company AnnouncementsGenflow Biosciences Raises £800,000 to Advance Gene Therapy Pipeline and Bolster Licensing Talks8M ago